Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Daumer

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Neurology|November 9, 2005
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trialsF Barkhof, U Held, J H Simon, et al.
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
European Journal of Neurology|February 6, 2013
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosisI Galea, C Lederer, A Neuhaus, et al.
Cell Cycle (Georgetown, Tex.)|June 22, 2010
Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitorsUbaldo E Martinez-Outschoorn, Stephanos Pavlides, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cellsUbaldo E Martinez-Outschoorn, Renee M Balliet, Dayana B Rivadeneira, et al.
The American Journal of Pathology|April 4, 2009
Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesionsIsabelle Mercier, Mathew C Casimiro, Jie Zhou, et al.
The American Journal of Pathology|April 28, 2009
Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signatureGloria Bonuccelli, Mathew C Casimiro, Federica Sotgia, et al.
The American Journal of Pathology|January 24, 2009
Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formationFederica Sotgia, Mathew C Casimiro, Gloria Bonuccelli, et al.
The American Journal of Pathology|February 24, 2009
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblastsFederica Sotgia, Francesco Del Galdo, Mathew C Casimiro, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neurology|November 9, 2005
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trialsF Barkhof, U Held, J H Simon, et al.
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
European Journal of Neurology|February 6, 2013
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosisI Galea, C Lederer, A Neuhaus, et al.
Cell Cycle (Georgetown, Tex.)|June 22, 2010
Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitorsUbaldo E Martinez-Outschoorn, Stephanos Pavlides, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cellsUbaldo E Martinez-Outschoorn, Renee M Balliet, Dayana B Rivadeneira, et al.
The American Journal of Pathology|April 4, 2009
Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesionsIsabelle Mercier, Mathew C Casimiro, Jie Zhou, et al.
The American Journal of Pathology|April 28, 2009
Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signatureGloria Bonuccelli, Mathew C Casimiro, Federica Sotgia, et al.
The American Journal of Pathology|January 24, 2009
Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formationFederica Sotgia, Mathew C Casimiro, Gloria Bonuccelli, et al.
The American Journal of Pathology|February 24, 2009
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblastsFederica Sotgia, Francesco Del Galdo, Mathew C Casimiro, et al.
Pageof 4